Works matching IS 13889842 AND DT 2022 AND VI 24 AND IP 5
Results: 30
Is targeting cyclic guanosine monophosphate by vericiguat effective to treat ischaemic heart failure with reduced ejection fraction? Yes, it is.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 791, doi. 10.1002/ejhf.2511
- By:
- Publication type:
- Article
Designing clinical trials in heart failure with preserved ejection fraction: quality over quantity?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 851, doi. 10.1002/ejhf.2510
- By:
- Publication type:
- Article
What's all the fuss about a new guideline?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 743, doi. 10.1002/ejhf.2509
- Publication type:
- Article
Uptitrating versus adding heart failure with reduced ejection fraction medications: bring more players to the game.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 885, doi. 10.1002/ejhf.2507
- By:
- Publication type:
- Article
Setting expectations for transcatheter mitral valve replacement in the real world.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 908, doi. 10.1002/ejhf.2506
- By:
- Publication type:
- Article
Tipping the scale toward a more accurate and equitable assessment of heart failure with reduced ejection fraction pharmacotherapy eligibility: a call to incorporate cystatin C in estimating glomerular filtration rate.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 867, doi. 10.1002/ejhf.2505
- By:
- Publication type:
- Article
Using the ejection fraction to guide medical therapy: a necessary but imperfect first step.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 779, doi. 10.1002/ejhf.2498
- Publication type:
- Article
Figures of the Heart Failure Association: Professor Finn Gustafsson, Board Member, 2020–2022.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 738, doi. 10.1002/ejhf.2502
- Publication type:
- Article
The interplay between sacubitril/valsartan, heart failure with preserved ejection fraction, diabetes and kidney function.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 804, doi. 10.1002/ejhf.2501
- By:
- Publication type:
- Article
Fluctuating iron levels in heart failure: when and where to look at?
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 818, doi. 10.1002/ejhf.2500
- By:
- Publication type:
- Article
Figures of the Heart Failure Association: Doctor Amina Rakisheva, Board Member, 2020–2022.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 741, doi. 10.1002/ejhf.2499
- Publication type:
- Article
Practical outpatient management of worsening chronic heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 750, doi. 10.1002/ejhf.2503
- By:
- Publication type:
- Article
New ESC/EACTS guideline recommendations for the treatment of secondary mitral regurgitation: reflections on the evidence.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 746, doi. 10.1002/ejhf.2497
- By:
- Publication type:
- Article
Reply to 'Exercise intolerance in heart failure: beyond mitochondrial dysfunction'. Letter regarding the article 'Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 910, doi. 10.1002/ejhf.2494
- By:
- Publication type:
- Article
Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1‐year results from the CHOICE‐MI registry.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 887, doi. 10.1002/ejhf.2492
- By:
- Publication type:
- Article
Responder analysis for improvement in 6‐min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 833, doi. 10.1002/ejhf.2491
- By:
- Publication type:
- Article
Impact of the COVID‐19 pandemic on prescription of sacubitril/valsartan in Italy.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 855, doi. 10.1002/ejhf.2490
- By:
- Publication type:
- Article
The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 762, doi. 10.1002/ejhf.2486
- By:
- Publication type:
- Article
Defining changes in physical limitation from the patient perspective: insights from the VITALITY‐HFpEF randomized trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 843, doi. 10.1002/ejhf.2481
- By:
- Publication type:
- Article
Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 821, doi. 10.1002/ejhf.2478
- By:
- Publication type:
- Article
Transapical mitral valve implantation for treatment of symptomatic mitral valve disease: a real‐world multicentre experience.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 899, doi. 10.1002/ejhf.2434
- By:
- Publication type:
- Article
Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 871, doi. 10.1002/ejhf.2477
- By:
- Publication type:
- Article
Exercise intolerance in heart failure: beyond mitochondrial dysfunction. Letter regarding the article 'Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?'.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 910, doi. 10.1002/ejhf.2461
- By:
- Publication type:
- Article
Eligibility for pharmacological therapies in heart failure with reduced ejection fraction: implications of the new Chronic Kidney Disease Epidemiology Collaboration creatinine equation for estimating glomerular filtration rate.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 861, doi. 10.1002/ejhf.2460
- By:
- Publication type:
- Article
Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 771, doi. 10.1002/ejhf.2455
- By:
- Publication type:
- Article
Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 794, doi. 10.1002/ejhf.2450
- By:
- Publication type:
- Article
Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 782, doi. 10.1002/ejhf.2468
- By:
- Publication type:
- Article
Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. 807, doi. 10.1002/ejhf.2251
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 5, p. i, doi. 10.1002/ejhf.2425
- Publication type:
- Article
May 2022 at a glance. Focus on treatment: from epidemiologic data to randomized trials and new devices.
- Published in:
- 2022
- By:
- Publication type:
- Editorial